PURUI Pharmaceutical was founded in 2004 , which has a fixed assets of 60 million yuan. The company focuses on R & D, manufacturing high quality active pharmaceutical ingredients (APIs), Pharmaceutical Intermediates , Tablets and Capsules. By strictly following the "Chinese Pharmacopoeia" the company has passed GMP approval and submitted DMF applications for APIs such as Clopidogrel Bisulfate and Fluconazole. As a specialized producer of API & Pharmaceutical Intermediates, Cardiovascular, Oncology, new antibiotic and anticholinergic products, the company is one of the Nations valued GMP Certificated Enterprises.
